Anisperimus

DB20564ExperimentalSmall molecule

Anisperimus is a small molecule drug. Anisperimus has a monoisotopic molecular weight of 401.31 Da.

Mechanism: Pharmacologically active on Inhibitor of nuclear factor kappa-B kinase subunit beta and Inhibitor of nuclear factor kappa-B kinase subunit alpha
Curator reviewed
Formula / weight: C₁₈H₃₉N₇O₃ · 401.556 g/mol (avg)
Code names: LF 15-0195

Resolves to

Compound

Structure

InChIKeyPZDPVSFZTKORSP-OAHLLOKOSA-NSMILESC[C@@H](N)CCNCCCCNC(=O)OCC(=O)NCCCCCCNC(N)=N

Targets

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Anisperimus, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.